IMDX

Insight Molecular Diagnostics
IMDX

Overview Fund Trends Analyst Outlook Journalist POV

39 hedge funds and large institutions have $18.1M invested in Insight Molecular Diagnostics in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

more funds holding in top 10

Funds holding in top 10: →

less funds holding

Funds holding: →

17% less capital invested

Capital invested by funds: $21.7M → $18.1M (-$3.61M)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
39
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$8.33M
2
+$61K
3
+$37K
4
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$27K
5
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
+$5.76K

Top Sellers

1
-$78K
2
-$63.1K
3
-$48K
4
TCIM
TIAA CREF Investment Management
New York
-$34K
5
TA
Teachers Advisors
New York
-$20K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1.75K
27
$1K
28
$1K
29
$1K
30
$1K
31
$1K
32
$1K
33
$1K
34
–
35
–
36
–
37
–
38
–
39
–
1
2